Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomised Study of Oral Prednisolone in Early Diffuse Cutaneous Systemic Sclerosis (Initially Double-blind, Then Switched to Open-label Because of Covid-19)

NCT03708718 is registered in ClinicalTrials.gov with Prof. Ariane herrick as lead sponsor.

NCT NCT03708718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03708718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomised Study of Oral Prednisolone in Early Diffuse Cutaneous Systemic Sclerosis (Initially Double-blind, Then Switched to Open-label Because of Covid-19)
Lead sponsor
Prof. Ariane herrick
Phase
Phase 2
Overall status
Completed
Start date
December 21, 2017
Completion date
May 27, 2021
Enrollment
35 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis